This episode outlines treatment barriers associated with the use of BTK inhibitors in CLL/SLL, including adverse events. Earn CME: https://www.naccme.com/oln
This episode address treatment barriers, adverse events, and healthcare disparities. Earn CME: https://www.naccme.com/oln
This episode discusses recently approved and emerging therapies in advanced HER2+ breast cancer. Earn CME: https://www.naccme.com/oln
This episode discusses the latest clinical trial data on current and emerging anti-androgen therapies in castration-resistant PC (CRPC) and hormone-sensitive PC (HSPC). Earn CME: https://www.naccme.com/oln
This episode identifies the strengths and limitations of molecular testing methodologies and genomic biomarkers for NSCLC identification, prognosis, and risk stratification. Earn CME: https://www.naccme.com/oln